Technical Analysis for SLXN - Silexion Therapeutics Ltd.

Grade Last Price % Change Price Change
F 0.33 47.26% 0.11
SLXN closed up 47.26 percent on Wednesday, November 20, 2024, on 30.66 times normal volume. It ran into resistance at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Crossed Above 20 DMA Bullish 0.00%
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

   Recent Intraday Alerts

Alert Time
Rose Above 20 DMA about 21 hours ago
Rose Above Previous Day's High about 21 hours ago
Rose Above Upper Bollinger Band about 21 hours ago
50 DMA Resistance about 21 hours ago
Rose Above 10 DMA about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Silexion Therapeutics is a pioneering clinical stage, oncology-focused biotechnology company dedicated to the development of innovative treatments for unsatisfactorily treated solid tumor cancers which have the mutated KRAS oncogene, generally considered to be the most common oncogenic gene driver in human cancers. The company conducted a Phase 2a clinical trial in its first-generation product which showed a positive trend in comparison to the control of chemotherapy alone. Silexion is committed to pushing the boundaries of therapeutic advancements in the field of oncology, and further developing its lead product candidate for locally advanced pancreatic cancer.
Classification

Sector: Financial Services
Industry: Shell Companies
Keywords: Biotechnology Cancer Oncology Chemotherapy Pancreatic Cancer Oncogenes Solid Tumor Cancers Human Cancers Ras Gtpase Oncogene Locally Advanced Pancreatic Cancer

Is SLXN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.5576
52 Week Low 0.2097
Average Volume 6,497,871
200-Day Moving Average 7.60
50-Day Moving Average 0.44
20-Day Moving Average 0.27
10-Day Moving Average 0.25
Average True Range 0.07
RSI (14) 44.13
ADX 37.41
+DI 35.49
-DI 23.87
Chandelier Exit (Long, 3 ATRs) 0.26
Chandelier Exit (Short, 3 ATRs) 0.41
Upper Bollinger Bands 0.34
Lower Bollinger Band 0.20
Percent B (%b) 0.98
BandWidth 50.41
MACD Line -0.11
MACD Signal Line -0.15
MACD Histogram 0.0447
Fundamentals Value
Market Cap 1.29 Million
Num Shares 3.87 Million
EPS 0.11
Price-to-Earnings (P/E) Ratio 3.03
Price-to-Sales 71.53
Price-to-Book 13.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.61
Resistance 3 (R3) 0.62 0.54 0.56
Resistance 2 (R2) 0.54 0.47 0.54 0.55
Resistance 1 (R1) 0.44 0.43 0.40 0.43 0.53
Pivot Point 0.36 0.36 0.34 0.35 0.36
Support 1 (S1) 0.25 0.29 0.21 0.24 0.13
Support 2 (S2) 0.18 0.25 0.17 0.12
Support 3 (S3) 0.07 0.18 0.10
Support 4 (S4) 0.06